These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25952033)

  • 1. Re: Generalizability of trial results to elderly medicare patients with advanced solid tumors.
    Mol L; Koopman M; Ottevanger PB; Punt CJ
    J Natl Cancer Inst; 2015 Jun; 107(6):djv104. PubMed ID: 25952033
    [No Abstract]   [Full Text] [Related]  

  • 2. Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802).
    Lamont EB; Schilsky RL; He Y; Muss H; Cohen HJ; Hurria A; Meilleur A; Kindler HL; Venook A; Lilenbaum R; Niell H; Goldberg RM; Joffe S;
    J Natl Cancer Inst; 2015 Jan; 107(1):336. PubMed ID: 25432408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes when cancer treatment is delivered on, or off, a clinical trial: implications for generalizability of study results.
    Markman M
    Oncology; 2011; 81(3-4):141-2. PubMed ID: 22024941
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of pancreatic carcinoma. Is there a role for radiotherapy and chemotherapy?
    Wils JA; Bleiberg H
    Acta Gastroenterol Belg; 1987; 50(1):114-20. PubMed ID: 2447729
    [No Abstract]   [Full Text] [Related]  

  • 5. Research in pancreatic cancer: an update after ASCO 2012.
    Saif MW
    JOP; 2012 Jul; 13(4):330-1. PubMed ID: 22797382
    [No Abstract]   [Full Text] [Related]  

  • 6. Extra-appendiceal neuroendocrine neoplasms in children - data from the GPOH-MET 97 Study.
    Redlich A; Wechsung K; Boxberger N; Leuschner I; Vorwerk P
    Klin Padiatr; 2013 Nov; 225(6):315-9. PubMed ID: 24158887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elderly patients with advanced pancreatic cancer: the generalizability of the results of clinical trials to daily clinical practice.
    Giuliani J; Bonetti A
    Recenti Prog Med; 2017 Mar; 108(3):152-154. PubMed ID: 28398410
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of pancreatic carcinoma: therapeutic nihilism?
    Wils JA
    Recent Results Cancer Res; 1988; 110():87-94. PubMed ID: 3043600
    [No Abstract]   [Full Text] [Related]  

  • 9. Vindesine and mitomycin in the treatment of advanced non-small cell lung cancer: a Southeastern Cancer Study Group Trial.
    Luedke DW; Luedke SL; Martelo O; Quesenberry P; Birch R; Schlueter J; Hake J; Logan T
    Cancer Treat Rep; 1986 May; 70(5):651-3. PubMed ID: 3011259
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of advanced pancreatic cancer with 5-fluorouracil, 4-epidoxorubicin and mitomycin C (FEM II). From the Chemotherapy of Gastrointestinal Tumors Group].
    Verhees S; Flechtner H; Queisser W; Heim ME; Fritz M; Trux F; Edler L
    Onkologie; 1990 Feb; 13(1):50-2. PubMed ID: 1692400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discussion - clinical trials and combination therapies in lung cancer. Clinical trial design.
    J Thorac Oncol; 2008 Jun; 3(6 Suppl 2):S176-8. PubMed ID: 18520307
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy helps patients with advanced non-small cell carcinoma of the lung.
    Socinski MA; Detterbeck FC; Rivera MP; Egan TM; Halle J; Rosenman J
    N C Med J; 1996; 57(5):281-6. PubMed ID: 8854691
    [No Abstract]   [Full Text] [Related]  

  • 13. Locally advanced non-metastatic pancreatic cancer--can we do more?
    Hawkins MA; Tait D
    Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):532-4. PubMed ID: 18614342
    [No Abstract]   [Full Text] [Related]  

  • 14. Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer.
    Stein SM; James ES; Deng Y; Cong X; Kortmansky JS; Li J; Staugaard C; Indukala D; Boustani AM; Patel V; Cha CH; Salem RR; Chang B; Hochster HS; Lacy J
    Br J Cancer; 2016 Mar; 114(7):737-43. PubMed ID: 27022826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOLFIRINOX in locally advanced pancreatic cancer: the starting point for questioning.
    Levy A; Chargari C; Huguet F; Védrine L; Deutsch E
    Pancreas; 2012 Aug; 41(6):973-4. PubMed ID: 22781912
    [No Abstract]   [Full Text] [Related]  

  • 16. The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors.
    Krug S; Gress TM; Michl P; Rinke A
    Digestion; 2017; 96(2):67-75. PubMed ID: 28728148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancer.
    Hotta K; Ueoka H; Kiura K; Tabata M; Tanimoto M
    Lung Cancer; 2004 Oct; 46(1):61-76. PubMed ID: 15364134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin for pancreatic cancer.
    Aung KL; Moore MJ
    Lancet Oncol; 2015 Jul; 16(7):748-9. PubMed ID: 26067686
    [No Abstract]   [Full Text] [Related]  

  • 19. Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.
    Lamont EB; Herndon JE; Weeks JC; Henderson IC; Lilenbaum R; Schilsky RL; Christakis NA
    J Natl Cancer Inst; 2005 Jul; 97(14):1080-3. PubMed ID: 16030306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of somatostatin analogs in the management of carcinoid tumors.
    Tomassetti P; Migliori M; Campana D; Brocchi E; Piscitelli L; Tomassetti V; Corinaldesi R
    J Endocrinol Invest; 2003; 26(8 Suppl):79-81. PubMed ID: 15233219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.